Serum levels of tissue inhibitor of metalloproteinases‐2 and of precursor form of matrix metalloproteinase‐2 in patients with liver disease
- 10 December 1997
- journal article
- Published by Wiley in Liver International
- Vol. 17 (6) , 293-299
- https://doi.org/10.1111/j.1600-0676.1997.tb01035.x
Abstract
Serum levels of tissue inhibitor of metalloproteinases‐2 (TIMP2) and of precursor form of matrix metalloproteinase‐2 (proMMP2) were determined in patients with chronic hepatitis and hepatocellular carcinoma by a one‐step sandwich enzyme immunoassay. Serum levels of TIMP2 and proMMP2 were significantly higher in patients with chronic liver disease, than in normal controls. Serum levels of TIMP2 showed a weak negative correlation with the serum albumin level and prothrombin time (PT). Serum levels of proMMP2 in patients with chronic hepatitis were strongly correlated with those of type IV collagen and were negatively correlated with PT and serum albumin levels. Serum proMMP2 levels were also significantly correlated with histological stages. These data indicate that serum levels of proMMP2 might be useful in the follow‐up of patients with chronic hepatitis.Keywords
This publication has 38 references indexed in Scilit:
- Circulating matrix metalloproteinase-2 and tissue inhibitor of metalloproteinase-1 as serum markers of fibrosis in patients with chronic hepatitis C: Relationship to interferon reponseJournal of Hepatology, 1997
- Changes in serum levels of metalloproteinases and their inhibitors by treatment of chronic hepatitis C with interferonDigestive Diseases and Sciences, 1996
- Classification of chronic hepatitis: Diagnosis, grading and stagingHepatology, 1994
- Tissue inhibitor of metalloproteinase is increased in the serum of precirrhotic and cirrhotic alcoholic patients and can serve as a marker of fibrosisHepatology, 1994
- Clinical evaluation of serum tissue inhibitor of metalloproteinases‐1 levels in patients with liver diseasesJournal of Gastroenterology and Hepatology, 1993
- Human hepatic lipocytes synthesize tissue inhibitor of metalloproteinases-1. Implications for regulation of matrix degradation in liver.Journal of Clinical Investigation, 1992
- Growth‐promoting activity of tissue inhibitor of metalloproteinases‐1 (TIMP‐1) for a wide range of cells A possible new growth factor in serumFEBS Letters, 1992
- Serum concentrations of the carboxyterminal cross-linking domain of procollagen type IV (NC1) and the aminoterminal propetide of procollagen type III (PIIIP) in chronic liver diseaseJournal of Hepatology, 1990
- High Metalloproteinase Inhibitor Content of Human Cirrhosis and Its Possible Conference of Metastasis Resistance2JNCI Journal of the National Cancer Institute, 1988
- Basement Membrane Production by Hepatocytes in Chronic Liver DiseaseHepatology, 1984